Cambridge Investment Research Advisors’s Universal Health Services UHS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,408
| Closed | -$252K | – | 4188 |
|
|
2026
Q1 | $252K | Sell |
1,408
-627
| -31% | -$129K | ﹤0.01% | 3443 |
|
|
2025
Q4 | $444K | Buy |
2,035
+49
| +2% | +$10.8K | ﹤0.01% | 2837 |
|
|
2025
Q3 | $406K | Buy |
1,986
+80
| +4% | +$14.4K | ﹤0.01% | 2852 |
|
|
2025
Q2 | $345K | Buy |
1,906
+175
| +10% | +$31.6K | ﹤0.01% | 2866 |
|
|
2025
Q1 | $325K | Sell |
1,731
-66
| -4% | -$12K | ﹤0.01% | 2789 |
|
|
2024
Q4 | $322K | Sell |
1,797
-195
| -10% | -$39.7K | ﹤0.01% | 2777 |
|
|
2024
Q3 | $456K | Sell |
1,992
-7
| -0.4% | -$1.51K | ﹤0.01% | 2485 |
|
|
2024
Q2 | $370K | Buy |
1,999
+501
| +33% | +$88.7K | ﹤0.01% | 2544 |
|
|
2024
Q1 | $273K | Sell |
1,498
-155
| -9% | -$25.6K | ﹤0.01% | 2777 |
|
|
2023
Q4 | $252K | Sell |
1,653
-1,523
| -48% | -$205K | ﹤0.01% | 2732 |
|
|
2023
Q3 | $399K | Sell |
3,176
-37,964
| -92% | -$5.18M | ﹤0.01% | 2274 |
|
|
2023
Q2 | $6.49M | Sell |
41,140
-19,862
| -33% | -$2.77M | 0.03% | 544 |
|
|
2023
Q1 | $7.75M | Buy |
61,002
+17,462
| +40% | +$2.41M | 0.04% | 445 |
|
|
2022
Q4 | $6.13M | Buy |
+43,540
| New | +$5.14M | 0.03% | 518 |
|
|
2021
Q3 | – | Sell |
-1,442
| Closed | -$211K | – | 3211 |
|
|
2021
Q2 | $211K | Sell |
1,442
-1,246
| -46% | -$188K | ﹤0.01% | 2788 |
|
|
2021
Q1 | $359K | Buy |
2,688
+357
| +15% | +$47.3K | ﹤0.01% | 2160 |
|
|
2020
Q4 | $321K | Buy |
+2,331
| New | +$290K | ﹤0.01% | 2076 |
|
|
2020
Q3 | – | Sell |
-34,633
| Closed | -$3.22M | – | 2599 |
|
|
2020
Q2 | $3.22M | Sell |
34,633
-2,257
| -6% | -$226K | 0.02% | 589 |
|
|
2020
Q1 | $3.65M | Buy |
36,890
+2,207
| +6% | +$279K | 0.04% | 465 |
|
|
2019
Q4 | $4.98M | Buy |
34,683
+2,738
| +9% | +$390K | 0.04% | 468 |
|
|
2019
Q3 | $4.75M | Buy |
31,945
+1,523
| +5% | +$219K | 0.04% | 429 |
|
|
2019
Q2 | $3.97M | Buy |
30,422
+2,945
| +11% | +$371K | 0.04% | 481 |
|
|
2019
Q1 | $3.68M | Sell |
27,477
-901
| -3% | -$119K | 0.04% | 480 |
|
|
2018
Q4 | $3.31M | Buy |
+28,378
| New | +$3.57M | 0.04% | 462 |
|
|
2017
Q3 | – | Sell |
-1,732
| Closed | -$211K | – | 2055 |
|
|
2017
Q2 | $211K | Buy |
+1,732
| New | +$206K | ﹤0.01% | 1721 |
|
|
2015
Q3 | – | Sell |
-2,386
| Closed | -$339K | – | 1585 |
|
|
2015
Q2 | $339K | Buy |
+2,386
| New | +$299K | 0.01% | 1005 |
|
Other funds holding UHS
Cambridge Investment Research Advisors's UHS Position: Q2 2026 in Review
Cambridge Investment Research Advisors sold out of Universal Health Services (UHS) in Q2 2026, closing a stake of 1,408 shares — an estimated $252K sold.
Cambridge Investment Research Advisors first reported a position in UHS in Q2 2015 and held it in 26 quarters. The position peaked at $7.75M in Q1 2023. 596 funds tracked by Wall St. Rank hold UHS as of Q2 2026.
- Cambridge Investment Research Advisors reported no remaining Universal Health Services position as of Q2 2026 after selling out during the quarter.
- Cambridge Investment Research Advisors sold 1,408 Universal Health Services shares in Q2 2026, an estimated $252K.
- Cambridge Investment Research Advisors first reported a position in Universal Health Services in Q2 2015 and held it in 26 quarters.
- Cambridge Investment Research Advisors's Universal Health Services position peaked at $7.75M in Q1 2023.
- 596 funds tracked by Wall St. Rank held Universal Health Services as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.